How to Build a Systematic Literature Review With Evidence Tables

AI made summaries faster

AI has made one part of literature work much easier: summarizing papers quickly. That is useful, but it also creates a dangerous illusion that the entire workflow has been solved.

The full review workflow still needs structure.

A serious literature review becomes valuable when another reader can see what was searched, what was screened out, what was extracted, how the evidence was structured, and why the final synthesis says what it says. The narrative is only one layer of the deliverable.

Why the evidence table matters so much

The evidence table is the point where the review becomes inspectable.

It preserves identifiers, study characteristics, endpoints, models, comparators, populations, biomarker context, limitations, and whatever fields the actual decision depends on. It also exposes contradiction. That matters because biotech literature is rarely as clean as a polished summary makes it appear.

Without that table, a review is harder to update and much easier to overstate.

Step 1: define a question that can actually be screened

A useful review brief should specify:

• the scientific or clinical question
• the relevant population or model system
• the time window
• what study types count
• what the output needs to support

A broad question often sounds ambitious and usually leads to loose extraction.

Step 2: keep the workflow stages separate

Search

This is about coverage.

Screening

This is about relevance. Search results are candidate evidence before they become accepted evidence.

Extraction

This is where the review becomes structured. The fields should match the actual decision the review is meant to support.

Synthesis

Only after the extraction frame is stable should the narrative be written.

When teams jump directly from search to synthesis, they usually lose analytical discipline.

Step 3: preserve the working set

A strong review should leave behind:

• the search frame
• the screened set
• the evidence table
• the narrative synthesis
• the contradictions, gaps, and unresolved questions

That combination gives the next analyst something to work with.

Step 4: write with restraint

A good review should keep the field as messy as the evidence requires. It should say where the evidence is strong, where it is mixed, where model systems may fail to translate, and where the negative space matters.

That is especially important in biotech, where too much confidence at the literature stage can distort everything downstream.

A reusable review is worth far more than a fast summary

The reason serious teams still care so much about review structure is that literature work rarely ends with one question. Once the core evidence table exists, it can support a diligence memo, a mechanism debate, a trial-design discussion, a grant background section, or a portfolio review.

That is why the table matters so much. It is the durable asset, while the narrative translates that asset for one audience and one moment.

How ARiDA helps

ARiDA treats this as a real PRISMA-style workflow rather than a long answer about papers. The Systematic Literature Review workflow is explicit about the chain of custody: identification, deduplication, screening, full-text extraction, evidence-table generation, flow diagram, certainty rating, and only then narrative synthesis.

That matters because the outputs are defined in advance. The literature specialist handles search and extraction. The live trial or database layer can cross-reference registry evidence when relevant. The coding specialist turns the extracted material into the evidence table, flow diagram, and certainty summary. The writing specialist only becomes useful after those materials exist. If the real need is pooled-effect meta-analysis rather than descriptive synthesis, the honest answer is to move into clinical biostatistics rather than to pretend the review engine already did more than it did.

The practical check

If the evidence table is missing, the review is probably weaker than it looks.

In literature-heavy biotech work, structure is what keeps speed from turning into superficiality.